A new algorithm uses a statistical approach to critical process parameter assessment, allowing for faster, more consistent, and less subjective critical process parameter quantification, visualization, and documentation.
Fasheng Li
Advertisement
Fasheng Li, PhD, is director of Pfizer’s department of pharmaceutical science and manufacturing statistics.
Articles by Fasheng Li
Advertisement
Latest Updated Articles
Removing Subjectivity from the Assessment of Critical Process Parameters and Their ImpactPublished: January 2nd 2018 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Sustainability and Stability in Excipients
2
CPHI 2025 Awards Spotlight Breakthroughs in Pharmaceutical Manufacturing and API Development
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
5
